AT293429B - Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren - Google Patents
Verfahren zur Herstellung von neuen Estern von N-substituierten CarbaminsäurenInfo
- Publication number
- AT293429B AT293429B AT535770A AT535770A AT293429B AT 293429 B AT293429 B AT 293429B AT 535770 A AT535770 A AT 535770A AT 535770 A AT535770 A AT 535770A AT 293429 B AT293429 B AT 293429B
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- substituted carbamic
- carbamic acids
- new esters
- esters
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2778768A GB1279412A (en) | 1968-06-11 | 1968-06-11 | Gastric hydrochloric acid secretion inhibitor, process for the manufacture of such compounds, pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion |
Publications (1)
Publication Number | Publication Date |
---|---|
AT293429B true AT293429B (de) | 1971-10-11 |
Family
ID=10265313
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT535970A AT298667B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von pharmazeutischen Zebereitungen |
AT535870A AT293430B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
AT535570A AT294849B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
AT535670A AT293428B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
AT552669A AT292012B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
AT535770A AT293429B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT535970A AT298667B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von pharmazeutischen Zebereitungen |
AT535870A AT293430B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
AT535570A AT294849B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
AT535670A AT293428B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
AT552669A AT292012B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
Country Status (11)
Country | Link |
---|---|
AT (6) | AT298667B (de) |
BE (1) | BE734033A (de) |
BR (1) | BR6909672D0 (de) |
CH (2) | CH525193A (de) |
DE (1) | DE1929416A1 (de) |
DK (1) | DK126035B (de) |
ES (3) | ES368207A1 (de) |
FR (2) | FR2010650B1 (de) |
GB (1) | GB1279412A (de) |
IE (1) | IE33149B1 (de) |
NL (1) | NL6908843A (de) |
-
1968
- 1968-06-11 GB GB2778768A patent/GB1279412A/en not_active Expired
-
1969
- 1969-06-04 BE BE734033D patent/BE734033A/xx unknown
- 1969-06-09 IE IE78169A patent/IE33149B1/xx unknown
- 1969-06-09 FR FR6919022A patent/FR2010650B1/fr not_active Expired
- 1969-06-10 ES ES368207A patent/ES368207A1/es not_active Expired
- 1969-06-10 NL NL6908843A patent/NL6908843A/xx unknown
- 1969-06-10 CH CH880769A patent/CH525193A/de not_active IP Right Cessation
- 1969-06-10 CH CH1500471A patent/CH539021A/de not_active IP Right Cessation
- 1969-06-10 DE DE19691929416 patent/DE1929416A1/de active Pending
- 1969-06-10 DK DK312369A patent/DK126035B/da unknown
- 1969-06-11 AT AT535970A patent/AT298667B/de not_active IP Right Cessation
- 1969-06-11 AT AT535870A patent/AT293430B/de not_active IP Right Cessation
- 1969-06-11 AT AT535570A patent/AT294849B/de not_active IP Right Cessation
- 1969-06-11 AT AT535670A patent/AT293428B/de not_active IP Right Cessation
- 1969-06-11 BR BR20967269A patent/BR6909672D0/pt unknown
- 1969-06-11 AT AT552669A patent/AT292012B/de not_active IP Right Cessation
- 1969-06-11 AT AT535770A patent/AT293429B/de not_active IP Right Cessation
-
1971
- 1971-02-27 ES ES71388702A patent/ES388702A1/es not_active Expired
- 1971-02-27 ES ES388703A patent/ES388703A1/es not_active Expired
-
1972
- 1972-06-14 FR FR7221354A patent/FR2140246A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE1929416A1 (de) | 1970-07-16 |
CH539021A (de) | 1973-08-31 |
AT292012B (de) | 1971-08-10 |
AT293428B (de) | 1971-10-11 |
CH525193A (de) | 1972-07-15 |
FR2140246A1 (de) | 1973-01-12 |
GB1279412A (en) | 1972-06-28 |
IE33149L (en) | 1969-12-11 |
ES388702A1 (es) | 1973-05-16 |
ES388703A1 (es) | 1974-02-16 |
IE33149B1 (en) | 1974-04-03 |
FR2010650B1 (de) | 1975-01-10 |
ES368207A1 (es) | 1972-04-16 |
BE734033A (de) | 1969-11-17 |
FR2010650A1 (de) | 1970-02-20 |
BR6909672D0 (pt) | 1973-03-13 |
AT294849B (de) | 1971-12-10 |
AT298667B (de) | 1972-05-25 |
DK126035B (da) | 1973-06-04 |
AT293430B (de) | 1971-10-11 |
NL6908843A (de) | 1969-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT285590B (de) | Verfahren zur herstellung von neuen furancarbonsaeuren und deren estern | |
AT327903B (de) | Verfahren zur herstellung von neuen estern und amiden von pyridin-2-carbonsauren | |
AT294053B (de) | Verfahren zur Herstellung von neuen γ-Hydroxy-γ-phenyl-γ-benzoylbuttersäuren, ihren Estern, Amiden oder Lactonen | |
CH522680A (de) | Verfahren zur Herstellung von Estern der 7(a-Amino-a-phenylacetamido)-cephalosporansäure | |
AT267509B (de) | Verfahren zur Herstellung von Estern | |
CH495939A (de) | Verfahren zur Herstellung von neuen Arylestern | |
AT306688B (de) | Verfahren zur Herstellung von ungesättigten Estern | |
AT282836B (de) | Verfahren zur Herstellung von neuen Estern des d-Pantothenols | |
AT293616B (de) | Verfahren zur Herstellung von neuen Estern der 6-Aminopenicillansäure | |
CH473149A (de) | Verfahren zur Herstellung von aktivierten Estern der 7-Aminocephalosporansäure | |
CH513822A (de) | Verfahren zur Herstellung von Indanyl-N-methylcarbaminsäureestern | |
CH507304A (de) | Verfahren zur Herstellung von Thionophosphonsäureestern | |
CH482729A (de) | Verfahren zur Herstellung von O-Alkyl-O-aryl-thiolphosphorsäureestern | |
AT291998B (de) | Verfahren zur Herstellung von neuen Amiden und Estern der 1-Hydroxy-benzimidazol-2-carbonsäure | |
AT286250B (de) | Verfahren zur Herstellung von γ-Chloracetessigsäureestern | |
AT293428B (de) | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren | |
CH459988A (de) | Verfahren zur Herstellung von Estern von Thio-carbonsäuren | |
AT310186B (de) | Verfahren zur Herstellung von neuen N-(Trihalogenmethylmercapto)-N-methylcarbamidsäure-arylestern | |
CH457435A (de) | Verfahren zur Herstellung von Estern von 3-indol-aliphatischen Säuren | |
CH538479A (de) | Verfahren zur Herstellung von neuen Estern von Hydroxy-isochinuclidin | |
AT300773B (de) | Verfahren zur Herstellung von neuen Estern der p-Biphenylylessigsäure | |
CH502334A (de) | Verfahren zur Herstellung von neuen Estern substituierter Phenylessigsäuren | |
AT291295B (de) | Verfahren zur Herstellung von neuen O-Alkyl-O-phenyl-thiolphosphorsäureestern | |
AT305494B (de) | Verfahren zur herstellung von neuen estern des 6-deoxy-5-oxytetracyclins | |
AT290554B (de) | Verfahren zur Herstellung von neuen Brom-alkyl-(di)-thiolphosphorsäureestern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |